DermTech Sponsors San Diego Open; Partners with Tennis Pro Brandon Nakashima to Raise Awareness for Sun Safety
Retrieved on:
Monday, September 27, 2021
General Health, Tennis, Sports, Other Health, Health, Adoption, Skin, Partnership, Inflammation, Melanoma, San Diego Open, ATP, Parent, Health, Security (finance), Private Securities Litigation Reform Act, NASDAQ, U.S. Securities and Exchange Commission, Medicare, Patient, Bruce Barnes (tennis), CEO, Genomics, Medicine, 250, Awareness, Tennis, Dermatology, SEC, Pharmaceutical industry, Medical imaging, Risk management
DermTech , Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the sponsorship of the San Diego Open , an ATP 250 tournament, and a partnership with San Diego native and tennis pro Brandon Nakashima.
Key Points:
- DermTech , Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today the sponsorship of the San Diego Open , an ATP 250 tournament, and a partnership with San Diego native and tennis pro Brandon Nakashima.
- The San Diego Open, held at the Barnes Tennis Center from September 27 through October 3, 2021, features a 28-player singles draw and a 16-team doubles draw.
- As a company deeply rooted in the San Diego community, DermTech is honored to sponsor the San Diego Open and kick-off a great partnership with Brandon Nakashima, said John Dobak, M.D., CEO of DermTech.
- We are looking forward to participating in this fantastic tennis event and bringing recognition to the importance of sun safety and skin health, in general.